COVID ‐19 vaccination around the time of conception and risk of placenta‐mediated adverse pregnancy outcomes
Acta Obstetricia et Gynecologica Scandinavica · 2025
DOI: 10.1111/aogs.70025 ↗At a glance
Journal article in Acta Obstetricia et Gynecologica Scandinavica, 2025. Written by Annette K Regan and 21 co-authors. Institution: Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA. Major MEDLINE topics: COVID-19 Vaccines, Pregnancy Outcome, COVID-19, Vaccination. Cited 4 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIAID NIH HHS, Public Health Agency of Canada, Norges Forskningsråd.
Abstract (original language)
Introduction Although numerous studies have documented no association between COVID‐19 vaccination during pregnancy and maternal and fetal health outcomes, fewer studies have evaluated fetal health effects after COVID‐19 vaccination around the time of conception and early pregnancy, a time when maternal exposures may affect early placentation and the subsequent risk of placenta‐mediated adverse pregnancy outcomes. Material and Methods We used province‐wide databases in Ontario to conduct a population‐based cohort study including all live and stillbirths ≥20 weeks' gestation with a last menstrual period (LMP) between April 1 and December 31, 2021. We deterministically linked birth registry data to the vaccine registry for all 80 253 eligible pregnancies; 31 209 (38.9%) received ≥1 dose of the COVID‐19 vaccine around the time of conception or first trimester. Using Cox regression, we estimated propensity score weighted hazard ratios (aHR) and 95% confidence intervals (CI) for associations between ≥1 dose of mRNA COVID‐19 vaccine during the periconceptional/first trimester exposure window (28 days before the LMP to the end of first trimester) and study outcomes: hypertensive disorders (gestational hypertension, preeclampsia, eclampsia), placental abruption, preterm birth (
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
- Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, USA.
- Better Outcomes Registry & Network (BORN) Ontario, Ottawa, Ontario, Canada.
- Children's Hospital of Eastern Ontario (CHEO) Research Institute, Ottawa, Ontario, Canada.
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.
- School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
ORCID profiles: Annette K Regan, Robert W Platt, Prakesh S Shah, Darine El-Chaâr, Nannette Okun
Funding
- NIAID NIH HHS
- Public Health Agency of Canada
- Norges Forskningsråd
- National Institute of Allergy and Infectious Diseases
- NordForsk
Cite
APA
Regan, A. K., Bruce, L., Lavin Venegas, C., Török, E., Platt, R. W., Gravel, C. A., Alton, G. D., Dimanlig-Cruz, S., Shah, P. S., Barrett, J., Walker, M. C., El-Chaâr, D., Wilson, K., Sprague, A. E., Buchan, S. A., Kwong, J. C., Wilson, S. E., Håberg, S. E., Okun, N., …, & Fell, D. B. (2025). COVID ‐19 vaccination around the time of conception and risk of placenta‐mediated adverse pregnancy outcomes. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70025
Vancouver
Regan AK, Bruce L, Lavin Venegas C, Török E, Platt RW, Gravel CA, et al. COVID ‐19 vaccination around the time of conception and risk of placenta‐mediated adverse pregnancy outcomes. Acta Obstetricia et Gynecologica Scandinavica. 2025. doi:10.1111/aogs.70025
BibTeX
@article{Regan2025,
author = {Regan, Annette K and Bruce, Liam and Lavin Venegas, Carolina and Török, Eszter and Platt, Robert W and Gravel, Christopher A and Alton, Gillian D and Dimanlig-Cruz, Sheryll and Shah, Prakesh S and Barrett, Jon and Walker, Mark C and El-Chaâr, Darine and Wilson, Kumanan and Sprague, Ann E and Buchan, Sarah A and Kwong, Jeffrey C and Wilson, Sarah E and Håberg, Siri E and Okun, Nannette and Dhinsa, Tavleen and Dunn, Sandra and Fell, Deshayne B},
title = {COVID ‐19 vaccination around the time of conception and risk of placenta‐mediated adverse pregnancy outcomes},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2025},
doi = {10.1111/aogs.70025}
}
EUVIMED